We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Distribution Alliance for Adhesion Prevention

By HospiMedica staff writers
Posted on 23 Jul 2002
Print article
According to a new European distribution agreement, a bioabsorbable gel for the prevention of adhesions will be marketed in Europe by Depuy AcroMed, Inc. (Chagrin Falls, OH, USA).

Called Oxiplex/SP Gel, the product is applied during spinal surgery to reduce postoperative internal scarring, or adhesions. Adhesions are a leading complication of many surgical procedures. Oxiplex is a new polymer technology formulated for a variety of targeted medical indications and markets by FzioMed, Inc. (San Luis Obispo, CA, USA)(The gel will be distributed to orthopedic surgeons and neurosurgeons for use in spinal surgical procedures such as laminectomy and discectomy. FzioMed will manufacture the product and provide sales support and training assistance.
AcroMed is a leading worldwide supplier of spinal products.

"There is a great unmet need for an effective antiadhesion product in spine surgery,” said Ronald Haynes, president and CEO of FzioMed. "We look forward to working with our partner to bring Oxiplex/SP to surgeons in Europe.”




Related Links:
FzioMed
DePuy AcroMed
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Dry Thawing & Warming System
SAHARA-TSC 230 V
New
Bone Marrow Biopsy Needle
BEST-LISAS

Print article

Channels

Surgical Techniques

view channel
Image: The machine learning approach identifies wrong-site surgeries (Photo courtesy of 123RF/Rawpixel)

World's First Machine Learning Model Combats Wrong-Site Surgery

Wrong-site surgery (WSS), classified as a critical "Never Event," represents a significant failure in healthcare that should never occur. However, due to widespread underreporting, the true frequency of... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.